PKG drug G1
This research compound, PKG drug G1, targets the C42 residue of PKG Iα. It induces vasodilation and lowers blood pressure through mechanisms that are independent of this specific PKG Iα interaction. It is a valuable tool for studying cyclic nucleotide signaling in cardiovascular research, both in vitro and in vivo.
Product Specifications
CAS Number
374703-78-3
Product Name Alternative
Inhibitor, inhibit, PKG drug G1, PKG drug G-1, PKG drug G 1, PKG
Field of Research
Signal Transduction
Purity
97.57% (May vary between batches)
Solubility
DMSO:16.67 mg/mL (64.79 mM)
Smiles
Cc1[nH]c2ccccc2c1\C=C1/NC (=S) NC1=O
Molecular Formula
C13H11N3OS
Molecular Weight
257.31
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV656446 1.0 µg DNA
DUSP11 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Sign In for Pricing
View Details FAB099U-100UG 100 µg
Human Leukotriene B4 R1 Alexa Fluor 350 Antibody
Sign In for Pricing
View Details 217819 2 mg
Syk Inhibitor V (S-2- (2- ((3,5-dimethylphenyl) amino) pyrimidin-4-yl) -N- (1-hydroxypropan-2-yl) -4-methylthiazole-5-carboxamide, Spleen Tyrosine Kinase Inhibitor)
Sign In for Pricing
View Details